Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 13–24 of 77 articles · Interpret the evidence
- Interpret the evidence
The difference between growth hormone peaks and troughs
CJC-1295 With DAC is a growth hormone–releasing hormone (GHRH) analogue that attaches to proteins in the blood, extending exposure. A human experiment asked whether sustained stimulation would change the timing or the size of growth hormone pulses.
CJC-1295 With DAC2 sources (2006, 2024)
- Interpret the evidence
What a two-peptide comparison showed about adding hormone responses
An older human experiment used unmodified GHRH(1–29) and GHRP-2 in eight healthy men. Each participant completed separate challenges with each compound and a challenge with both, in randomized order.
CJC-1295 (No DAC) / GHRP-22 sources (1995, 2024)
- Interpret the evidence
How researchers separated pulse regularity from average hormone output
CJC-1295 (No DAC) / GHRP-2 groups a modified growth hormone–releasing hormone fragment with pralmorelin, a six-residue ghrelin-receptor agonist. One research question is how the broader hormone environment can change the pattern observed when two signals act together.
CJC-1295 (No DAC) / GHRP-22 sources (2002, 2024)
- Interpret the evidence
Why food intake is a separate endpoint from growth hormone
CJC-1295 (No DAC) / GHRP-2 describes a pairing of a modified growth hormone–releasing hormone analogue with GHRP-2, also known as pralmorelin. Could a short growth hormone experiment by itself explain what happens to eating behavior?
CJC-1295 (No DAC) / GHRP-22 sources (2005, 2024)
- Interpret the evidence
Distinguishing a GHRP-6 heart study from evidence about the blend
CJC-1295 (No DAC) / GHRP-6 combines a name commonly used for a four-substitution relative of growth hormone–releasing hormone with GHRP-6, a six-residue peptide known to activate the ghrelin receptor.
CJC-1295 (No DAC) / GHRP-62 sources (2024, 2026)
- Interpret the evidence
What a Small DSIP Study in Healthy Volunteers Can Tell Us
Delta sleep-inducing peptide, called DSIP or emideltide, was tested in an early human study that asked how sleep changed in healthy volunteers. No recent controlled study addressing that same healthy-volunteer question was identified, so the original report is the direct source.
DSIP2 sources (1981, 2026)
- Interpret the evidence
Why the DSIP Withdrawal Reports Cannot Establish a Treatment Effect
Peptides are short chains of amino acids linked by peptide bonds. Researchers sometimes test whether a chain influences several signals at once, but a change in symptoms can have more than one cause.
DSIP3 sources (1984–2026)
- Interpret the evidence
Why DSIP Free Form and Acetate Need Separate Evidence Checks
Delta sleep-inducing peptide, or DSIP, illustrates why both levels of description are useful. The FDA's July 2026 briefing considered emideltide in its free form and emideltide acetate as distinct bulk substances.
DSIP1 source (2026)
- Interpret the evidence
Why the Epitalon Telomere Result Depended on the Cell Type
Epitalon is the tetrapeptide Ala-Glu-Asp-Gly. Its study in normal and cancer cell lines makes a useful point about interpreting laboratory results: two samples can show the same change in a measurement while arriving there through different processes.
Epitalon2 sources (2025, 2026)
- Interpret the evidence
Why a comparison group matters in inclusion body myositis
Follistatin is a larger binding protein. FST344 denotes the precursor of the mature FST315 form. A 2017 study used an investigational FST344 gene transfer approach in people with sporadic inclusion body myositis and compared their walking results with those of people from the same clinic.
Follistatin 3442 sources (2017, 2026)
- Interpret the evidence
What the early rat comparison found about glucose and insulin
Fragment 176–191 is the last 16 residues of the mature human growth hormone chain. An older primary study directly included a synthetic version of this sequence in a comparison of six fragments.
Fragment 176-1913 sources (1978–2026)
- Interpret the evidence
Why a brief hormone rise did not translate into greater height in a trial
GHRP-2, or pralmorelin, is a synthetic six-residue peptide that activates the ghrelin receptor. An older pediatric trial tested whether repeated transient increases in growth hormone (GH) were associated with greater height gains.
GHRP-22 sources (2014, 2025)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
